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Introduction {#cam41216-sec-0001}
============

Oral squamous cell carcinoma (OSCC) is ranked as the eighth most common malignant cancer worldwide according to the WHO global oral health programme [1](#cam41216-bib-0001){ref-type="ref"}. The incidence of OPSCC ranges from 1/10,0000 to 10/10,0000 in the world, which will likely increase gradually in the coming years [2](#cam41216-bib-0002){ref-type="ref"}, [3](#cam41216-bib-0003){ref-type="ref"}. It is worth noting that the mortality of OSCC patients in developing countries was higher than their counterparts in developed countries [2](#cam41216-bib-0002){ref-type="ref"}. Moreover, in the GLOBOCAN 2008 report, 128000 deaths were caused by OSCC worldwide in 2008 [4](#cam41216-bib-0004){ref-type="ref"}. Therefore, it is imperative to develop an accurate model to evaluate OSCC patient prognosis.

Currently, the National Comprehensive Cancer Network (NCCN) clinical practice guidelines recommended assessing a prognosis via the American Joint Committee on Cancer (AJCC) Staging Manual (7th edition) [5](#cam41216-bib-0005){ref-type="ref"}, [6](#cam41216-bib-0006){ref-type="ref"}. However, the outcome of OSCC patients is influenced by many other factors such as age, sex, race, tumor site, radiation, and surgery [2](#cam41216-bib-0002){ref-type="ref"}, [7](#cam41216-bib-0007){ref-type="ref"}, [8](#cam41216-bib-0008){ref-type="ref"}, [9](#cam41216-bib-0009){ref-type="ref"}. Hence, consideration of other relevant clinicopathological factors could provide a more credible prediction result than the AJCC staging manual. Therefore, we sought to construct a "nomogram" to identify other elements including age, sex, tumor site, pathological grade, surgery or not, radiation or not and TNM classifications. The nomograms were established with a popular random split‐sample method [10](#cam41216-bib-0010){ref-type="ref"}, [11](#cam41216-bib-0011){ref-type="ref"}, [12](#cam41216-bib-0012){ref-type="ref"}. Moreover, researchers obtained a favorable model via a split‐ratio of 1:1 and 1:2 [13](#cam41216-bib-0013){ref-type="ref"}. Nomograms were validated internally and externally through the concordance index (C‐index) and calibration plot [12](#cam41216-bib-0012){ref-type="ref"}.

A nomogram\'s construction was based on the independent prognostic factors via Kaplan‐Meier and multivariate Cox proportional hazards model. Currently, a nomogram has been widely used to assist surgeons in developing treatment plans and evaluating the prognosis of cancers such as hepatocellular carcinoma [14](#cam41216-bib-0014){ref-type="ref"}, gastric cancer [15](#cam41216-bib-0015){ref-type="ref"}, nasopharyngeal cancer [16](#cam41216-bib-0016){ref-type="ref"} and breast cancer [17](#cam41216-bib-0017){ref-type="ref"}. Most importantly, the early detection of prostate cancers via nomogram had been written into the NCCN clinical guidelines [18](#cam41216-bib-0018){ref-type="ref"}. Hence, we sought to establish two nomograms to assess the 5‐ and 8‐year OS and CSS based on the SEER database to provide a reference to surgeons.

Materials and Methods {#cam41216-sec-0002}
=====================

Patients\' general information {#cam41216-sec-0003}
------------------------------

We collected the clinicopathological data of all 10,533 OSCC patients from the years 2004 to 2012 from the SEER program of the National Cancer Institute [19](#cam41216-bib-0019){ref-type="ref"}. The detailed information included age, sex, race, ethnic origin, tumor site, grade, surgery, radiation, T stage, N stage and M stage (Table [1](#cam41216-tbl-0001){ref-type="table-wrap"}). The minimum age was 15 years old. The racial composition consisted of white, black and others (American Indian/AK Native, Asian/Pacific Islander). Tumor sites comprised hard palate, cheek, mouth floor and tongue (excluded tongue base).

###### 

Patients\' clinicopathological data

  Variables   Modeling group (*n* = 7046)   Validation group (*n* = 3487)          
  ----------- ----------------------------- ------------------------------- ------ ------
  Age                                                                              
  15--35      285                           4.0                             161    4.6
  36--45      615                           8.7                             301    8.6
  46--55      1606                          22.8                            816    23.4
  56--65      2001                          28.4                            966    27.7
  66--75      1402                          19.9                            671    19.2
  76--85      842                           12.0                            440    12.6
  85+         292                           4.2                             132    3.8
  Sex                                                                              
  Male        4224                          59.9                            2148   61.6
  Female      2825                          40.1                            1339   38.4
  Site                                                                             
  HP          445                           6.3                             212    6.1
  Cheek       665                           9.4                             353    10.1
  MF          1622                          23.0                            774    22.2
  Tongue      4314                          61.2                            2148   61.6
  Race                                                                             
  White       5776                          82.0                            2902   83.2
  Black       595                           8.4                             252    7.2
  Others      675                           9.6                             333    9.5
  Origin                                                                           
  NSHL        6444                          91.5                            3193   91.6
  SHL         602                           8.5                             294    8.4
  Grade                                                                            
  I           1683                          23.9                            813    23.3
  II          4050                          57.5                            2020   57.9
  III         1278                          18.1                            628    18.0
  IV          35                            0.5                             26     0.7
  Surgery                                                                          
  Performed   6079                          86.3                            3034   87.0
  None        967                           13.7                            453    13.0
  Radiation                                                                        
  Yes         3194                          45.3                            1565   44.9
  No          3852                          54.7                            1922   55.1
  T stage                                                                          
  T1          3273                          46.5                            1592   45.7
  T2          1981                          28.1                            1059   30.4
  T3          723                           10.3                            339    9.7
  T4          1069                          15.2                            497    14.2
  N stage                                                                          
  N0          4626                          65.7                            2335   67.0
  N1          1001                          14.2                            483    13.9
  N2          1352                          19.2                            637    18.2
  N3          67                            1.0                             32     0.9
  M stage                                                                          
  M0          6941                          98.5                            3442   98.7
  M1          105                           1.5                             45     1.3

HP, Hard Palate; MF, Mouth Floor. Others, American Indian/AK Native, Asian/Pacific Islander; NSHL, Nonspanish‐Hispanic‐Latino; Grade I, Well differentiated; II, Moderately differentiated; III, Poorly differentiated; IV, Undifferentiated.
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Survival analysis {#cam41216-sec-0004}
-----------------

We also obtained the survival data by searching with the SAS name "srv_time_mon", "STAT_REC", "VSRTSADX". The SAS names "STAT_REC", "VSRTSADX" represented the overall survival (OS) and cancer‐specific survival (CSS) of patients, respectively. We excluded the patients whose information was collected from autopsy and death certificates. We conducted OS and CSS analyses using the Kaplan‐Meier and Cox Proportional hazards models, which is consistent with a research study published in JAMA Oncol [20](#cam41216-bib-0020){ref-type="ref"}. All statistical analyses were performed applying a two‐sided *P* value and *P* \< 0.05 was considered statistically significant.

Nomogram development {#cam41216-sec-0005}
--------------------

We acquired the independent prognostic factors with regard to OS and CSS of OSCC patients by virtue of SPSS 21.0 software for Windows. We conducted the nomograms via the "cmprsk package" of R software version 3.2.4.

Nomogram validation {#cam41216-sec-0006}
-------------------

The nomogram\'s accuracy was required to be validated by 1000 times bootstrapping and 10‐fold cross‐validation measures internally and externally. The fitting degree was evaluated by concordance indexes (C‐index) and calibration plots [12](#cam41216-bib-0012){ref-type="ref"}. The C‐index and calibration were obtained by the "rcorrcens" and "calibrate" commands in R software. In addition, the calibration plot consisted of two lines: one was a 45‐degree reference line, and the other line represented the actual line. The interval between the two lines reflected the accuracy of the nomograms.

Results {#cam41216-sec-0007}
=======

Patient clinicopathological data {#cam41216-sec-0008}
--------------------------------

After strict filtering based on the SEER database, 7046 and 3487 OSCC patients were included in the modeling and validation cohorts, respectively, via the popular random split‐sample method (the split ratio was 2:1). The patients\' ages ranged from 15 to 96 years (median, 55) in the modeling cohort. Of these, 7046 OSCC patients, 4224(59.9%) were male. A total of 5776 (82.0%) patients were white, and 6444 (91.5%) patients were non‐Spanish‐Hispanic‐Latino. With regard to tumor sites, 4314(61.2%) tumors were located on the tongue (excluded tongue base) and 1622 (23.0%) were primarily found on the mouth floor. In addition, 5733 (81.4%) were well and moderately defined. Of these cases, 6079 (86.3%) received surgery and 3194 (45.3%) underwent radiotherapy. The proportions of T1--T2 and T3--T4 were 74.6% (5254/7046) and 25.5% (1792/7046), respectively. The N0 and M0 tumors accounted for 65.7% and 98.5% of the total specimens, respectively. The detailed information for the validation cohort is shown in Table [1](#cam41216-tbl-0001){ref-type="table-wrap"}.

Survival analysis and nomogram construction {#cam41216-sec-0009}
-------------------------------------------

In terms of the SAS variable "sur_time_mon" in the SEER database, we found that the median follow‐up periods of the modeling and validation cohorts were 31 months (1--119 months) and 33 months (1--119 months). According to the SAS variables "STAT_REC" and "VSRTSADX" in SEER database, we acquired credible data on the overall survival (OS) and cancer‐specific death (CSD) for 10533 OSCC patients. In total, 3064 (43.5%) patients in the modeling cohort were deceased at the last follow‐up date. Among those patients, 2196 (31.2%) patients died due to OSCC. Additionally, 868 (12.3%) patients died due to other causes rather than OSCC.

We conducted the univariate and multivariate analysis targeting overall survival (OS) and cancer‐specific survival (CSS) via SPSS 21.0 software for Windows (Table [2](#cam41216-tbl-0002){ref-type="table-wrap"} and [3](#cam41216-tbl-0003){ref-type="table-wrap"}). The results of univariate and multivariate survival analyses showed that age, sex, tumor sites, race, pathological grade, surgery, radiation and TNM staging were independent prognostic factors, which showed statistical significance (*P *\< 0.05). Then, we established a nomogram to take all these elements into account, as shown in Figure [1](#cam41216-fig-0001){ref-type="fig"}. Meanwhile, we carried out an analysis focusing on cancer‐specific survival using SPSS software. The results of univariate and multivariate survival analyses indicated that age, site, race, pathological grade, surgery and TNM classifications were the independent risk elements influencing the prognosis. Furthermore, we constructed another nomogram predicting the 5‐ and 8‐year CSS (Fig. [2](#cam41216-fig-0002){ref-type="fig"}).

###### 

Univariate and multivariate analyses of OS in nomogram cohort

                        Multivariate analysis   
  ----------- --------- ----------------------- ---------
  Age         \<0.001                           \<0.001
  15--35                0.202 (0.154--0.266)    \<0.001
  36--45                203 (0.166--0.249)      \<0.001
  46--55                0.239 (0.203--0.282)    \<0.001
  56--65                0.295 (0.252--0.345)    \<0.001
  66--75                0.376 (0.321--0.440)    \<0.001
  76--85                0.579 (0.493--0.679)    \<0.001
  85+                   Reference               
  Sex         \<0.001                           0.002
  Male                  Reference               
  Female                0.888 (0.823--0.959)    0.002
  Site        \<0.001                           \<0.001
  HP                    0.672 (0.567--0.797)    \<0.001
  Cheek                 0.960 (0.848--1.088)    0.526
  MF                    1.085 (0.996--1.181)    0.061
  Tongue                Reference               
  Race        \<0.001                           \<0.001
  White                 Reference               
  Black                 1.132 (1.006--1.275)    0.040
  Others                0.781 (0.681--0.896)    \<0.001
  Origin      0.281                             
  NSHL                                          
  SHL                                           
  Grade       \<0.001                           \<0.001
  I                     0.546 (0.344--0.867)    0.010
  II                    0.689 (0.437--1.087)    0.109
  III                   0.795 (0.502--1.259)    0.328
  IV                    Reference               
  Surgery     \<0.001                           \<0.001
  Performed             Reference               
  None                  2.090 (1.905--2.293)    \<0.001
  Radiation   \<0.001                           \<0.001
  Yes                   Reference               
  No                    1.119 (1.026--1.221)    0.011
  T stage     \<0.001                           \<0.001
  T1                    0.403 (0.358--0.452)    \<0.001
  T2                    0.671 (0.604--0.744)    \<0.001
  T3                    0.983 (0.873--1.106)    0.772
  T4                    Reference               
  N stage     \<0.001                           \<0.001
  N0                    0.426 (0.319--0.570)    \<0.001
  N1                    0.691 (0.515--0.925)    0.013
  N2                    0.925 (0.694--1.233)    0.602
  N3                    Reference               
  M stage     \<0.001                           \<0.001
  M0                    0.586 (0.472--0.728)    \<0.001
  M1                    Reference               

HP, Hard palate; MF, mouth floor. Others: American Indian/AK Native, Asian/Pacific Islander. NSHL: Nonspanish‐Hispanic‐Latino. Grade I: Well differentiated. II: Moderately differentiated. III: Poorly differentiated. IV: Undifferentiated.
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###### 

Univariate and multivariate analyses of CSS in nomogram cohort

                        Multivariate analysis   
  ----------- --------- ----------------------- ---------
  Age                                           
  15--35                0.361 (0.268--0.485)    \<0.001
  36--45                0.322 (0.255--0.407)    \<0.001
  46--55                0.363 (0.299--0.441)    \<0.001
  56--65                0.407 (0.337--0.492)    \<0.001
  66--75                0.486 (0.401--0.590)    \<0.001
  76--85                0.664 (0.543--0.812)    \<0.001
  85+                   Reference               
  Sex         0.136                             
  Male                                          
  Female                                        
  Site        \<0.001                           0.004
  HP                    0.685 (0.559--0.840)    \<0.001
  Cheek                 1.021 (0.884--1.179)    0.777
  MF                    0.977 (0.883--1.082)    0.655
  Tongue                Reference               
  Race        \<0.001                           0.037
  White                 Reference               
  Black                 1.112 (0.971--1.274)    0.125
  Others                0.862 (0.739--1.006)    0.060
  Origin      0.108                             
  NSHL                                          
  SHL                                           
  Grade       \<0.001                           \<0.001
  I                     0.535 (0.317--0.902)    0.019
  II                    0.699 (0.418--1.169)    0.172
  III                   0.799 (0.476--1.342)    0.397
  IV                    Reference               \<0.001
  Surgery                                       \<0.001
  Performed             Reference               
  None                  2.260 (2.032--2.514)    \<0.001
  Radiation   \<0.001                           0.252
  Yes                   Reference               
  No                    1.062 (0.958--1.178)    0.252
  T stage     \<0.001                           \<0.001
  T1                    0.364(0.318--0.417)     \<0.001
  T2                    0.669 (0.594--0.753)    \<0.001
  T3                    0.992 (0.869--1.133)    0.906
  T4                    Reference               
  N stage     \<0.001                           \<0.001
  N0                    0.328 (0.242--0.445)    \<0.001
  N1                    0.603 (0.444--0.821)    0.001
  N2                    0.834 (0.618--1.125)    0.235
  N3                    Reference               
  M stage     \<0.001                           \<0.001
  M0                    0.549 (0.434--0.693)    \<0.001
  M1                    Reference               

HP, Hard palate; MF, Mouth Floor. Others: American Indian/AK Native, Asian/Pacific Islander. NSHL, Nonspanish--Hispanic--Latino. Grade I: Well differentiated. II: Moderately differentiated. III: Poorly differentiated. IV: Undifferentiated.
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![Nomogram predicting 5‐year and 8‐year OS. HP, Hard Palate; MF, Mouth Floor; Others, American Indian/Alaska Native/Asian or Pacific Islander; Grade I, Well differentiated; II, Moderately differentiated; III, Poorly differentiated; IV, undifferentiated.](CAM4-7-943-g001){#cam41216-fig-0001}

![Nomogram predicting 5‐year and 8‐year CSS. HP, Hard Palate; MF, Mouth Floor; Others, American Indian/Alaska Native/Asian or Pacific Islander; Grade I, Well differentiated; II, Moderately differentiated; III, Poorly differentiated; IV, undifferentiated. ***Nomogram validation:*** The nomograms were validated by bootstrap resampling and tenfold cross‐validation methods. The Harrell concordance index (C‐index) and calibration curves were used to evaluate the accuracy of the nomograms internally and externally. The predicted OS and CSS conformed to the actual OS and CSS if the value of C‐index was greater than 0.7. Our results of internal validation indicated that the C‐index values of OS and CSS were 0.762 and 0.783, respectively. External validation showed that the C‐index value of OS and CSS increased slightly to 0.773 and 0.800. Additionally, the internal and external calibration curves approached the 45‐degree ideal straight line (Figs. [3](#cam41216-fig-0003){ref-type="fig"} and [4](#cam41216-fig-0004){ref-type="fig"}).](CAM4-7-943-g002){#cam41216-fig-0002}

Discussion {#cam41216-sec-0010}
==========

OSCC was ranked as the eighth most prevalent cancer in the world [21](#cam41216-bib-0021){ref-type="ref"}. Due to the higher incidence and mortality of OSCC according to the statistics of the World Health Organization, oral cancers became the burden of public health [2](#cam41216-bib-0002){ref-type="ref"}. Most importantly, the WHO Global Oral Health Programme constructed a global surveillance system to evaluate the risk factors of OSCC [2](#cam41216-bib-0002){ref-type="ref"}. Generally, surgery and radiation were the main measures to address OSCC [5](#cam41216-bib-0005){ref-type="ref"}, [22](#cam41216-bib-0022){ref-type="ref"}. However, in this large‐sample retrospective research, we found that 1420 (13.5%) and 5774 (54.8%) cases did not receive surgery and radiation, respectively. Meanwhile, early detection of OSCC was still a serious problem [23](#cam41216-bib-0023){ref-type="ref"}. Current studies indicated that more OSCC patients were diagnosed with an advanced stage, influencing the survival of OSCC patients seriously [24](#cam41216-bib-0024){ref-type="ref"}. Thus, it is imperative to establish an accurate prediction model to guide surgeons to conduct OSCC\'s early detection and prognostic evaluation individually. Additionally, the 8th AJCC staging system indicated that they would assess the prognosis by taking consideration the nomogram in the future version [25](#cam41216-bib-0025){ref-type="ref"}. Hence, establishing a credible nomogram prediction model remained a top priority.

We calculated the estimated overall survival (OS) and cancer‐specific survival (CSS) via Kaplan‐Meier method, which was consistent with the research published in JAMA Oncol [20](#cam41216-bib-0020){ref-type="ref"}. In the survival analysis of OS, we found that the OS of females was higher than males (Fig. [1](#cam41216-fig-0001){ref-type="fig"} and Table [2](#cam41216-tbl-0002){ref-type="table-wrap"}). Meanwhile, the female\'s CSS was superior to male, although it did not show statistical significance (Table [3](#cam41216-tbl-0003){ref-type="table-wrap"}). The results above were consistent with retrospective research in the United Kingdom [26](#cam41216-bib-0026){ref-type="ref"}. We hypothesized that males were susceptible to indulge in smoking and drinking alcohol, which was closely linked to OSCC [27](#cam41216-bib-0027){ref-type="ref"}. In terms of age, we found that the OS and CSS descended beyond the year of 55. Those aged "15--35" and "36--45" had an improved OS and CSS, respectively. Current results have shown that the majority of OSCC patients were diagnosed after the age of 50 [9](#cam41216-bib-0009){ref-type="ref"}. Our results indicated that the OS and CSS of black OSCC patients were lower than that of other races, which was consistent with the research [28](#cam41216-bib-0028){ref-type="ref"}. One research study hypothesized that melanin might contribute to the development of OSCC [29](#cam41216-bib-0029){ref-type="ref"}. The OSCC patients had an improved OS and CSS after surgery and radiation therapy (Figs. [1](#cam41216-fig-0001){ref-type="fig"} and [2](#cam41216-fig-0002){ref-type="fig"}; Tables [2](#cam41216-tbl-0002){ref-type="table-wrap"} and [3](#cam41216-tbl-0003){ref-type="table-wrap"})

We validated the accuracy of nomograms internally (modeling cohort) and externally (validation cohort) by virtue of C‐index and calibration curves. We split the total 10533 specimens with a random split‐sample method and the split‐ratio was 2:1, which was in accordance with the research [10](#cam41216-bib-0010){ref-type="ref"}. The C‐indexes of internal validation regarding 5‐ and 8‐year OS and CSS were 0.762 and 0.783, respectively. In addition, the external validation\'s C‐indexes were 0.772 and 0.800. The values of the C‐index were all greater than 0.7 and there was excellent coherence between the calibration curves and the 45‐degree ideal lines (Figs. [3](#cam41216-fig-0003){ref-type="fig"} and [4](#cam41216-fig-0004){ref-type="fig"}).

![Internal calibration nomogram for 5‐year and 8‐year OS (A, C) and 5‐year and 8‐year CSS (B, D). The 45‐degree line represents an ideal match between the actual survival (*Y*‐axis) and nomogram‐predicted survival (*X*‐axis). The perpendicular line means 95% confidence intervals.](CAM4-7-943-g003){#cam41216-fig-0003}

![External calibration nomogram for 5‐year and 8‐year OS (A, C) and 5‐year and 8‐year CSS (B, D). The 45‐degree line represents an ideal match between the actual survival (*Y*‐axis) and nomogram‐predicted survival(*X*‐axis). The perpendicular line means 95% confidence intervals.](CAM4-7-943-g004){#cam41216-fig-0004}

The process of creating nomograms to forecast the 5‐ and 8‐year OS and CSS was simple and feasible. First, we drew vertical lines from the clinicopathological factors to the axes of the points. After acquiring the total points, we plotted the vertical lines from the total points to the axes of 5‐ and 8‐year OS and CSS to obtain the predicted values. Most importantly, using the nomogram to predict a prognosis was more accurate than using the AJCC staging manual. For example, two types of T3N0M0 OSCC patients: type 1, a 55‐year‐old black male patient with grade IV disease who received surgery and radiation; and type 2, a 60‐year‐old white female patient with grade II disease underwent surgery only. The prognoses of these two types of patients were identical if we used the AJCC staging manual [6](#cam41216-bib-0006){ref-type="ref"}. However, the results were different via the nomogram. The 5‐year predicted OS for the type 1 and type 2 patients were 57% and 68%, respectively. Moreover, the CSS of the type 1 and 2 patients was 64% and 81%, respectively. Hence, we constructed two accurate nomogram models to predict the prognoses of the OSCC patients.

Our research had strengths and certain limitations. We completed a large‐sample retrospective study based on the SEER database and succeeded in establishing more accurate nomogram models. A lot of researches had shown that other relevant clinicopathological factors were influenced the survival of patients with oral cancers such as HPV [30](#cam41216-bib-0030){ref-type="ref"}, nodal involvement [31](#cam41216-bib-0031){ref-type="ref"}, thickness of the tumor [32](#cam41216-bib-0032){ref-type="ref"}, P53 [33](#cam41216-bib-0033){ref-type="ref"}, EGFR [34](#cam41216-bib-0034){ref-type="ref"}, cigarette and alcohol consumption [35](#cam41216-bib-0035){ref-type="ref"}, and chemotherapy [5](#cam41216-bib-0005){ref-type="ref"}. However, the SEER database didn\'t include these elements above. For the same reason, we could not evaluate disease‐free survival and loco‐regional control. Hence, our nomogram could not assess these factors. We will conduct a prospective study to detect these indicators to remedy these limitations.

In conclusion, we conducted the survival analysis conscientiously and succeeded in establishing two accurate nomograms, which can provide surgeons with a reference to tailor clinical therapeutic regimens and provide a personalized prognosis.

Conflicts of Interests {#cam41216-sec-0012}
======================

None declared.

We express our deep gratitude to Hui Zhang, Jiao Wen and Bingkun Cheng for their assistance with data analysis.
